|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0023977,
umls-concept:C0025266,
umls-concept:C0060389,
umls-concept:C0301630,
umls-concept:C0426731,
umls-concept:C0439810,
umls-concept:C0750502,
umls-concept:C1274040,
umls-concept:C1441416,
umls-concept:C1442488,
umls-concept:C1514721,
umls-concept:C1696465,
umls-concept:C1707455
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2008-8-11
|
|
pubmed:abstractText |
In the present analysis we examined data from the MTOPS (Medical Therapy of Prostatic Symptoms) trial to determine the effect of long-term finasteride treatment, either alone or in combination with doxazosin, on total prostate volume across the full range of baseline total prostate volume values in men enrolled in this study.
|
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/U01 DK 49912,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK41418,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK46416,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK46429,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK46431,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK46437,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK46468,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK46472,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK49880,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK49921,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK49951,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK49954,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK49960,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK49961,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK49963,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK49964,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK49971,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK49977,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK49980
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1527-3792
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
180
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1030-2; discussion 1032-3
|
|
pubmed:meshHeading |
pubmed-meshheading:18639298-Adrenergic alpha-Antagonists,
pubmed-meshheading:18639298-Aged,
pubmed-meshheading:18639298-Doxazosin,
pubmed-meshheading:18639298-Drug Therapy, Combination,
pubmed-meshheading:18639298-Enzyme Inhibitors,
pubmed-meshheading:18639298-Finasteride,
pubmed-meshheading:18639298-Humans,
pubmed-meshheading:18639298-Male,
pubmed-meshheading:18639298-Middle Aged,
pubmed-meshheading:18639298-Prostate,
pubmed-meshheading:18639298-Prostatic Hyperplasia,
pubmed-meshheading:18639298-Time Factors
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Long-term treatment with finasteride results in a clinically significant reduction in total prostate volume compared to placebo over the full range of baseline prostate sizes in men enrolled in the MTOPS trial.
|
|
pubmed:affiliation |
Weill Cornell Medical College, New York, New York 10021, USA. kaplans@med.cornell.edu
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
